06/06/2023 |
SynAct Pharma AB |
Thomas Boesen |
Other member of the company's administrative, management or supervisory body |
|
Allotment |
Personaloptioner serie 2023 II i SynAct Pharma AB |
Option |
|
01/06/2023 |
65,000 |
Quantity |
0.00 |
SEK |
|
Notification
|
01/06/2023 |
SynAct Pharma AB |
Björn Westberg |
Chief Financial Officer (CFO) |
|
Allotment |
Personaloptioner serie 2023 II i SynAct Pharma AB |
Option |
|
01/06/2023 |
65,000 |
Quantity |
0.00 |
SEK |
|
Notification
|
18/01/2023 |
SynAct Pharma AB |
James Knight |
Other member of the company's administrative, management or supervisory body |
|
Subscription |
SynAct Pharma AB |
Share |
SE0008241491 |
16/01/2023 |
77,452 |
Quantity |
62.60 |
SEK |
|
Notification
|
18/01/2023 |
SynAct Pharma AB |
Torbjörn Bjerke |
Chairman of the Board of Directors |
|
Subscription |
SynAct Pharma AB |
Share |
SE0008241491 |
16/01/2023 |
15,355 |
Quantity |
62.60 |
SEK |
|
Notification
|
17/01/2023 |
SynAct Pharma AB |
Thomas Jonassen |
Member of the Board of Directors |
Yes |
Subscription |
SynAct Pharma AB |
Share |
SE0008241491 |
16/01/2023 |
15,355 |
Quantity |
62.60 |
SEK |
|
Notification
|
17/01/2023 |
SynAct Pharma AB |
Thomas Boesen |
Other member of the company's administrative, management or supervisory body |
Yes |
Subscription |
SynAct Pharma AB |
Share |
SE0008241491 |
16/01/2023 |
32,917 |
Quantity |
62.60 |
SEK |
|
Notification
|
17/01/2023 |
SynAct Pharma AB |
Thomas Boesen |
Other member of the company's administrative, management or supervisory body |
|
Allotment |
Personaloptioner serie 2023/2027 i SynAct Pharma AB |
Option |
|
13/01/2023 |
90,000 |
Quantity |
0.00 |
SEK |
|
Notification
|
17/01/2023 |
SynAct Pharma AB |
Jeppe Øvlesen |
Chief Executive Officer (CEO)/Managing Directory |
Yes |
Subscription |
SynAct Pharma AB |
Share |
SE0008241491 |
16/01/2023 |
1,161,777 |
Quantity |
62.60 |
SEK |
|
Notification
|
17/01/2023 |
SynAct Pharma AB |
Jeppe Øvlesen |
Chief Executive Officer (CEO)/Managing Directory |
Yes |
Subscription |
SynAct Pharma AB |
Share |
SE0008241491 |
16/01/2023 |
13,825 |
Quantity |
62.60 |
SEK |
|
Notification
|
13/01/2023 |
SynAct Pharma AB |
Patrik Renblad |
Chief Financial Officer (CFO) |
|
Allotment |
Personaloptioner serie 2023/2027 i SynAct Pharma AB |
Option |
|
13/01/2023 |
90,000 |
Quantity |
0.00 |
SEK |
|
Notification
|